Call Us: +44 (0) 1752 753723[email protected]

05
Sep

Human blood cells leukaemia x400mag

Fantastic news today as children with leukaemia will be able to access CAR-T therapy on the NHS. The CAR-T cells in this pilot have been derived from peripheral blood. Groups are working on the same process using CAR-T cells from umbilical cord blood, a non-invasive source of therapeutic cells. Biovault’s Shaun Mansfield, a stem cell scientist specialising in umbilical cord cells says: “We’re delighted at this step forward in cell-based therapies.”